21 CFR 522.1156
§ 522.1156 Imidocarb solution.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 522.1156, § 522.1156 Imidocarb solution, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87464
- Permanent ID
ys:prov:87464@1- SHA-256
da91e7eb165048ae9dfce376654763769d08b7b16a471491ded7b468c1a43c9b
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each milliliter of solution contains 120 milligrams (mg) of imidocarb dipropionate.
(b) Sponsor. See No. 000061 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs—(1) Amount. Administer 6.6 mg per kilogram (3 mg per pound) of body weight by intramuscular or subcutaneous injection. Repeat the dose after 2 weeks for a total of two treatments.
(2) Indications for use. For the treatment of clinical signs of babesiosis and/or demonstrated Babesia organisms in the blood.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.